Project Details
| Status | Active |
|---|---|
| Effective start/end date | 08/17/24 → 08/16/26 |
Funding
- Neurocrine Biosciences Incorporated: $6,435.00
A Randomized Double-Blind Placebo-Controlled Parallel-Group Study to Evaluate the Efficacy Safety and Tolerability of Luvadaxistat in Subjects With Cognitive Impairment Associated With Schizophrenia
- Gil, Roberto (PI)
- Perlman, Greg (CoPI)
Project: Research